131 related articles for article (PubMed ID: 11135041)
1. Expression of CD44 and its variant isoform v3 has no prognostic value in gastric cancer.
Setälä L; Lipponen P; Tammi R; Tammi M; Eskelinen M; Alhava E; Kosma VM
Histopathology; 2001 Jan; 38(1):13-20. PubMed ID: 11135041
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD44 variant 6 and lymphatic invasion: importance to lymph node metastasis in gastric cancer.
Kurozumi K; Nishida T; Nakao K; Nakahara M; Tsujimoto M
World J Surg; 1998 Aug; 22(8):853-7; discussion 857-8. PubMed ID: 9673558
[TBL] [Abstract][Full Text] [Related]
3. CD44 loss in gastric stromal tumors as a prognostic marker.
Montgomery E; Abraham SC; Fisher C; Deasel MR; Amr SS; Sheikh SS; House M; Lilliemoe K; Choti M; Brock M; Ephron DT; Zahuruk M; Chadburn A
Am J Surg Pathol; 2004 Feb; 28(2):168-77. PubMed ID: 15043305
[TBL] [Abstract][Full Text] [Related]
4. CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach.
Cao X; Cao D; Jin M; Jia Z; Kong F; Ma H; Wang Y; Jiang J
BMC Gastroenterol; 2014 Sep; 14():157. PubMed ID: 25212506
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer.
Kodama H; Murata S; Ishida M; Yamamoto H; Yamaguchi T; Kaida S; Miyake T; Takebayashi K; Kushima R; Tani M
Br J Cancer; 2017 Jan; 116(2):186-194. PubMed ID: 27931044
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis.
Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava E; Kosma VM
Scand J Gastroenterol; 1998 Mar; 33(3):301-9. PubMed ID: 9548625
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of CD44 isoform expression in endometrial cancer.
Tempfer C; Haeusler G; Kaider A; Hefler L; Hanzal E; Reinthaller A; Breitenecker G; Kainz C
Br J Cancer; 1998 Apr; 77(7):1137-9. PubMed ID: 9569051
[TBL] [Abstract][Full Text] [Related]
8. CD44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer.
Tempfer C; Sliutz G; Haeusler G; Speiser P; Reinthaller A; Breitenecker G; Vavra N; Kainz C
Br J Cancer; 1998 Oct; 78(8):1091-4. PubMed ID: 9792156
[TBL] [Abstract][Full Text] [Related]
9. High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer.
Lipponen P; Aaltomaa S; Tammi R; Tammi M; Agren U; Kosma VM
Eur J Cancer; 2001 May; 37(7):849-56. PubMed ID: 11313172
[TBL] [Abstract][Full Text] [Related]
10. [Expressions of CD133 and CD44 in gastric adenocarcinoma and their relationship with E-cadherin expression].
Lu G; Wu X; Zhou L; Yu L; Wu S
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Nov; 33(11):1632-7. PubMed ID: 24273267
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD44v3, erythropoietin and VEGF-C in gastric adenocarcinomas: correlations with clinicopathological features.
Wang L; Li HG; Wen JM; Peng TS; Zeng H; Wang LY
Tumori; 2014; 100(3):321-7. PubMed ID: 25076245
[TBL] [Abstract][Full Text] [Related]
12. The Prognostic Value of CD44 Expression in Epithelial-Mesenchymal Transition: Preliminary Data from Patients with Gastric and Esophageal Cancer.
Schizas D; Moris D; Kanavidis P; Michalinos A; Sioulas A; Pavlakis K; Machairas A; Liakakos T
In Vivo; 2016 11-12; 30(6):939-944. PubMed ID: 27815484
[TBL] [Abstract][Full Text] [Related]
13. CD44(+) CD324(-) expression and prognosis in gastric cancer patients.
Cao L; Hu X; Zhang J; Liang P; Zhang Y
J Surg Oncol; 2014 Nov; 110(6):727-33. PubMed ID: 24910454
[TBL] [Abstract][Full Text] [Related]
14. Expression of moesin and CD44 is associated with poor prognosis in gastric adenocarcinoma.
Jung WY; Kang Y; Lee H; Mok YJ; Kim HK; Kim A; Kim BH
Histopathology; 2013 Oct; 63(4):474-81. PubMed ID: 23889297
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Cyclin D1 and CD44 Expression in Gastric Adenocarcinoma.
Ibrahim HM; AbdElbary AM; Mohamed SY; Elwan A; Abdelhamid MI; Ibrahim A
J Gastrointest Cancer; 2019 Sep; 50(3):370-379. PubMed ID: 29497929
[TBL] [Abstract][Full Text] [Related]
16. CD44 and CD44v6 are Correlated with Gastric Cancer Progression and Poor Patient Prognosis: Evidence from 42 Studies.
Fang M; Wu J; Lai X; Ai H; Tao Y; Zhu B; Huang L
Cell Physiol Biochem; 2016; 40(3-4):567-578. PubMed ID: 27889771
[TBL] [Abstract][Full Text] [Related]
17. [Expression tumor stem cell surface marker CD44 in gastric cancer and its significance].
Xie JW; Huang CM; Zheng CH; Li P; Wang JB; Lin JX; Lu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Nov; 16(11):1107-12. PubMed ID: 24277411
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of CD44 standard, variant isoforms 3 and 6 and -catenin expression in local prostate cancer treated by radical prostatectomy.
Aaltomaa S; Lipponen P; Viitanen J; Kankkunen JP; Ala-Opas M; Kosma VM
Eur Urol; 2000 Nov; 38(5):555-62. PubMed ID: 11096236
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of CD44 and nm23 expression in patients with stage II and stage IIIA gastric carcinoma.
Yoo CH; Noh SH; Kim H; Lee HY; Min JS
J Surg Oncol; 1999 May; 71(1):22-8. PubMed ID: 10362087
[TBL] [Abstract][Full Text] [Related]
20. CD44 variant overexpression in gallbladder carcinoma associated with tumor dedifferentiation.
Yanagisawa N; Mikami T; Mitomi H; Saegusa M; Koike M; Okayasu I
Cancer; 2001 Jan; 91(2):408-16. PubMed ID: 11180088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]